VVT Medical receives FDA 510(k) clearance for its ScleroSafe System
FDA Clearance received 60 days from submission and paves way for Commercialization in the United States KFAR SABA, Israel, June 21, 2023 /PRNewswire/ — VVT Medical, a global medical device company, announces today the receipt of a 510(k) clearance for its ScleroSafe™ platform by the U.S. Food and Drug Administration (FDA). ScleroSafe advanced technology by VVT … Read more